<DOC>
	<DOCNO>NCT01050543</DOCNO>
	<brief_summary>This randomize , active-controlled , parallel-group , single-dose , multi-site , safety-assessor blind study compare sugammadex neostigmine reversal neuromuscular blockade Korean subject undergo elective surgical procedure general anesthesia require rocuronium neuromuscular blockade . Study medication administer reappearance T2 . Time recovery measure start study medication administration recovery T4/T1 ratio 0.9 . The primary hypothesis time recovery T4/T1 ratio 0.9 shorter sugammadex neostigmine .</brief_summary>
	<brief_title>Comparison Sugammadex With Neostigmine Reversal Agents Rocuronium Reappearance T2 ( Study P06101 )</brief_title>
	<detailed_description />
	<mesh_term>Neostigmine</mesh_term>
	<criteria>American Society Anesthesiologists Class 1 2 3 &gt; =18 year age either sex schedule elective surgical procedure general anesthesia require use rocuronium endotracheal intubation and/or maintenance neuromuscular blockade supine position allow neuromuscular transmission monitor require reversal neuromuscular blockade Korean descent bear Korea , never emigrate Korea , Korean home address expect difficult intubation due anatomic malformation expect transfer intensive care unit surgery neuromuscular disorder affect neuromuscular blockade significant hepatic renal dysfunction require use pneumatic tourniquet surgery ( family ) history malignant hyperthermia allergy cyclodextrins ( include sugammadex ) medication ( ) use general anesthesia ; use toremifene fusidic acid within 24 hour study drug administration ; contraindication use neostigmine glycopyrrolate</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>